| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 12,543 | 13,223 | 13,254 | 14,944 | | Cost of Revenue | 8,654 | 7,990 | 8,102 | 9,521 | | | Gross Profit | 3,889 | 5,233 | 5,152 | 5,423 | | | Operating Expenses | | Research Development | 2,419 | 2,485 | 2,613 | 2,493 | | Selling General and Administrative | 3,246 | 3,777 | 4,734 | 4,600 | | Non Recurring | 307 | 409 |
-
| 9,799 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,083) | (1,438) | (2,195) | (11,469) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (69) | 101 | 54 | 210 | | Earnings Before Interest And Taxes | (2,152) | (1,337) | (2,141) | (11,259) | | Interest Expense | (79) | 79 |
-
| 117 | | Income Before Tax | (2,073) | (1,416) | (2,141) | (11,376) | | Income Tax Expense |
-
|
-
| 8 |
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,073) | (1,416) | (2,149) | (11,376) | | | Non-recurring Events | | Discontinued Operations | 132 | 130 | 109 | (1,073) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,941) | (1,286) | (2,040) | (12,449) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,941) | ($1,286) | ($2,040) | ($12,449) |
|
0.10% Nasdaq 
0.17%
Income Statement
